Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.13 USD | -2.52% | -9.36% | -27.80% |
05-09 | BioXcel Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-09 | Transcript : BioXcel Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-27.80% | 79.94M | |
+5.33% | 111B | |
+12.11% | 106B | |
-12.56% | 22.24B | |
-3.70% | 21.25B | |
-6.03% | 18.97B | |
-35.21% | 18.52B | |
-10.86% | 16.81B | |
+5.10% | 13.94B | |
+37.57% | 12.54B |
- Stock Market
- Equities
- BTAI Stock
- News BioXcel Therapeutics, Inc.
- UBS Adjusts BioXcel Therapeutics Price Target to $3.50 From $4, Maintains Neutral Rating